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A B S T R A C T
Cardiac Purkinje cells (PCs) are implicated in lethal arrhythmias caused by cardiac diseases, mutations, and drug
action. However, the pro-arrhythmic mechanisms in PCs are not entirely understood, particularly in humans, as
most investigations are conducted in animals. The aims of this study are to present a novel human PCs elec-
trophysiology biophysically-detailed computational model, and to disentangle ionic mechanisms of human
Purkinje-related electrophysiology, pacemaker activity and arrhythmogenicity. The new Trovato2020 model
incorporates detailed Purkinje-specific ionic currents and Ca2+ handling, and was developed, calibrated and
validated using human experimental data acquired at multiple frequencies, both in control conditions and fol-
lowing drug application. Multiscale investigations were performed in a Purkinje cell, in fibre and using an
experimentally-calibrated population of PCs to evaluate biological variability. Simulations demonstrate the
human Purkinje Trovato2020 model is the first one to yield: (i) all key AP features consistent with human
Purkinje recordings; (ii) Automaticity with funny current up-regulation (iii) EADs at slow pacing and with 85%
hERG block; (iv) DADs following fast pacing; (v) conduction velocity of 160 cm/s in a Purkinje fibre, as reported
in human. The human in silico PCs population highlights that: (1) EADs are caused by ICaL reactivation in PCs
with large inward currents; (2) DADs and triggered APs occur in PCs experiencing Ca2+ accumulation, at fast
pacing, caused by large L-type calcium current and small Na+/Ca2+ exchanger. The novel human Purkinje
model unlocks further investigations into the role of cardiac Purkinje in ventricular arrhythmias through
computer modeling and multiscale simulations.
1. Introduction
Cardiac Purkinje cells (PCs) play a crucial role in ventricular ex-
citation since they guarantee a correct excitation pattern and therefore
a synchronised sequence of cardiac contraction. Mounting evidence
identifies PCs as an important trigger of arrhythmias [1]. Particularly,
PCs may be involved in the generation of Torsade de Pointes
arrhythmias [2], associated with the long QT syndrome [3], either
genetic or drug-induced. Indeed, PCs obtained often from dog or rabbit
hearts are a cardiac preparation commonly used for preclinical cardi-
otoxicity screening [4].
Purkinje and ventricular cardiomyocytes are different both in
structure and electrophysiology. The main structural difference is the
low density of t-tubuli in PCs [5], which induces spatial heterogeneity
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of Ca2+ cycling [6]. The action potential (AP) of PCs is characterised by
a faster depolarisation phase, a more negative plateau and a longer AP
duration (APD) compared to ventricular APs [1,7]. Due to their longer
APD, PCs may be more prone than ventricular myocytes to develop pro-
arrhythmic abnormalities, i.e. early and delayed after-depolarisation
(EADs and DADs, respectively) [2]. Interestingly, experimental studies
have reported that PCs with a less negative diastolic membrane po-
tential (DMP) show automaticity, whereas, well-polarised PCs do not
[7,8].
Isolation of PCs requires challenging procedures which make the
investigation of the electrophysiological properties of PCs difficult
compared to other types of cardiomyocytes [9]. Furthermore, experi-
ments on PCs are not usually conducted in human but rather in animal
models such as guinea pig, rabbit, dog, cow, sheep, all exhibiting sig-
nificant interspecies differences in structure, electrophysiology and
calcium handling [10–12]. Thus, mechanistic complexity, limited ac-
cess to human tissue and experimental and ethical constraints impair
our understanding of the ionic mechanisms and contribution to human
arrhythmias of the Purkinje system.
The goals of our study are to integrate current knowledge on human
PC electrophysiology through the development of the novel computa-
tional Trovato2020 model, and to investigate mechanisms of pro-ar-
rhythmic abnormalities in human PC through cellular and tissue si-
mulation studies. Human Purkinje voltage-clamp data [9], novel and
partly published AP measurements [13], as well as information from
the literature were used to develop, calibrate and validate the Tro-
vato2020 model. The model structure incorporates Purkinje-specific
ionic currents and a detailed Ca2+ subsystem, as in a recently published
canine model (PRd, [14]), which were not considered in previously
published human Purkinje-based computational models (STW [15];
TT08 [16]; SMP [17]). Simulations with the new Trovato2020 model: i)
reproduce experimental recordings in a wide range of protocols as well
as electrophysiological alterations following selective hERG and Ca2+
channels blocks; ii) explain the ionic mechanisms underlying pro-ar-
rhythmic abnormalities and automaticity. Biological variability was
also studied through the construction and evaluation of a populations of
models [18,19] to investigate and explain the mechanisms underlying
EADs, DADs and triggered activity in human Purkinje cardiomyocytes.
Electrical propagation was successfully simulated in a human Purkinje
fibre. The Trovato2020 model is available on the CellML repository
(www.cellml.org) as well as in several formats (Matlab, C++ and
Fortran) in the Oxford Computational Cardiovascular Science Team
website (www.cs.ox.ac.uk/ccs).
2. Materials and methods
2.1. Experimental data
Three different experimental datasets were used in this study for
calibration, optimisation and validation of the novel human cardiac
Purkinje electrophysiology Trovato2020 model:
• Dataset I. Ionic current recordings from [9]. These consist of the I-V
curves for the transient and sustained outward potassium currents
(Ito and Isus, respectively) and for the inward potassium rectifier
current (IK1), as well as Ito steady state inactivation/activation
curves, and inactivation time constants. Data were acquired from
n = 20 PCs isolated from free-running false tendons from N = 9
failing human hearts.
• Dataset II. AP recordings from n = 17 Purkinje fibres from N = 7
undiseased human hearts, acquired at multiple frequencies - basic
cycle length (BCL) from 400 to 5000 ms - partly published in [13].
AP recordings were analysed to extract the following 9 biomarkers:
maximum upstroke velocity (dV/dtMAX); AP duration (APD) at 90%,
75%, 50%, 25% and 10% of repolarisation (APD90, APD75, APD50,
APD25, APD10); AP Amplitude (APA); membrane potential before
depolarisation (TOP, take-off potential); membrane potential at the
end of repolarisation (EOP, end of potential). Table 1 shows the
minimum and maximum experimental values for each biomarker
and BCL. A graphical visualisation of the data is presented in Fig. S1
(Supplementary Material).
• Dataset III. AP recordings from n = 3 Purkinje fibres from N = 3
undiseased human hearts obtained with the same procedures used
for ventricular trabeculae described previously [20]. 30 consecutive
APs for each fibre were recorded at 1 and 2 Hz under control con-
ditions (DMSO 0.1%), and with 100 nM dofetilide.
As explained below, Datasets I and II were used for model devel-
opment and calibration, while Dataset III was used exclusively for
model validation.
2.2. Strategy for model design, calibration and validation
Fig. 1A illustrates the design, calibration, optimisation, and vali-
dation of the Trovato2020 model, described in more detail below and in
the Supplementary Material, Section 1. The Trovato2020 model pre-
sented in this study was built based on the ionic formulations of the
O'Hara-Rudy human ventricular model, ORd [21], and the Purkinje-
specific Ca2+ sub-system, cellular compartments and intracellular ionic
Table 1
Experimental AP biomarkers.
BCL (ms)
400 500 700 1000 1500 2000 3000 5000
Min Max Min Max Min Max Min Max Min Max Min Max Min Max Min Max
dV/dtMax (V/s) 242 576 176 674 176 644 154 688 195 605 195 625 195 625 151 625
APD90 (ms) 167 288 173 338 175 389 187 438 177 445 178 415 179 470 180 497
APD75 (ms) 146 253 150 298 151 346 166 384 155 394 157 371 157 421 159 453
APD50 (ms) 114 199 118 246 121 292 124 349 122 339 127 292 125 365 129 392
APD25 (ms) 32 137 39 148 45 167 31 185 34 209 20 147 19 218 25 226
APD10 (ms) 2 65 1.4 63 1 82 1 107 1 75 1 23 1 86 1 91
APA (mV) 101 115 101 115 91 115 93 116 93 122 92 115 94 123 89 115
TOP (mV) −88 −80 −89 −75 −90 −76 −91 −79 −92 −77 −87 −76 −93 −77 −88 −73
EOP (mV) −91 −85 −89 −79 −90 −75 −94 −81 −93 −77 −89 −77 −93 −77 −88 −72
Minimum and maximum experimental values for the 9 AP biomarkers recorded in human cardiac Purkinje cells at multiple BCL: 400 ms (n = 7), 500 ms (n = 7),
700 ms (n = 9), 1000 (n = 17), 1500 ms (n = 9), 2000 ms (n = 7), 3000 (n = 8), 5000 ms (n = 8).
BCL: Basic cycle length; dV/dtMAX: maximum upstroke velocity; APDx: AP duration at X% of repolarisation; APA: action potential amplitude; TOP: membrane
potential before depolarisation; EOP: membrane potential at the end of repolarisation.
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fluxes of the canine Purkinje AP model, PRd [14], also used by Britton
et al. [19]. Fig. 1B reports a diagrammatic representation of the model
structure. In brief, the Trovato2020 model includes the ORd mathe-
matical formulation for each of the following currents: fast Na+ current
(INa), Na+ late component (INaL), L-type Ca2+ current (ICaL), rapid and
slow delayed K+ rectifiers (IKr and IKs, respectively), Na+-Ca2+ ex-
changer (INCX) and Na+-K+ pump (INaK). Ito, Isus and IK1 were for-
mulated based on the Dataset I. In addition, two Purkinje-specific
currents from the PRd model were included: T-type Ca2+ current (ICaT)
and funny current (If). Existing knowledge from the literature on the
ionic current differences between ventricular and PCs, and between
human and canine PCs, was also taken into account.
The Trovato2020 model was developed to fulfil the following 6
criteria:
1) Consistency with the experimental AP biomarkers at all BCLs: si-
mulated values had to be within the experimental ranges shown in
Table 1.
2) APD90 rate-dependence: APD90 increase for BCLs between 400 ms
and 2000 ms.
3) APD90 changes induced by ICaL modulation: APD90 increase/short-
ening in response to ICaL up/down regulation. The effect of ICaL on
APD90 has been shown experimentally, using selective Ca2+
blockers such as diltiazem [22] and nifedipine [23], i.e., ICaL re-
duction induces AP shortening, whereas ICaL increase leads to AP
prolongation. Due to the lack of quantitative information and
human data, we only imposed a positive correlation between
changes in APD90 (ΔAPD90) and ICaL up/down regulation
(|ΔAPD90| > 0.5% with±30% ICaL).
4) APD90 prolongation induced by IKr block. Experimental studies by
[24] showed IKr block led to a longer APD in Purkinje than in
ventricular cardiomyocytes. Thus, during calibration, we imposed
the APD using the Trovato2020 model to be longer than the one
obtained using the ventricular ORd model for both 30% and 50% IKr
Fig. 1. A) Schematic representation of the human Purkinje model development strategy. Blue: model development stages; green: data processing for calibration and
optimisation; yellow: sensitivity analysis; orange: criteria for model development; purple: model validation and applications; red hearts: experimental datasets. B)
Main structure and ionic currents of the Trovato2020 Purkinje AP model. The intracellular space is represented with 3 different compartments: peripheral coupling
subspace (SS), sub-sarcolemma (SL), and bulk myoplasm (MYO). The sarcoplasmic reticulum (SR) also consists of 3 compartments: junctional (JSR), network (NSR),
and corbular (CSR). 18 dynamic current models are included for Na+ (blue), K+ (purple) and Ca2+ (brown) channels, Na+-K+ pump, and Na+-Ca2+ exchanger
(yellow). Intracellular Ca2+ release and up-take fluxes (green) are distributed across the 3 SR compartments. Ca2+ buffers are shown as blue clouds. Global CaMKII
phosphorylation is also included, and the affected currents are marked by a spiky circle. (For interpretation of the references to colour in this figure legend, the reader
is referred to the web version of this article.)
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block.
5) Ability to generate EADs, reported experimentally in canine PCs
[25,26].
6) Ability to generate DADs and/or triggered APs, as reported for ca-
nine PCs [27,28].
Starting from the initial model described above, a sensitivity ana-
lysis was performed to investigate how properties relevant to the 6
criteria were affected by variations in the ionic current parameters, and
to guide the definition of a calibrated model (details in the
Supplementary material, Section 1 and Fig. S2-S3). Parameter optimi-
sation was then performed using a multi-objective genetic algorithm
[29]. The conductances of the main currents, namely INa, INaL, ICaL, ICaT,
Ito, Isus, IKr, IKs, If, IK1, INCX, INaK, as well as 7 parameters for ICaL and IKr
kinetics were allowed to vary in the ranges reported in Table S1,
building on the sensitivity analysis results. The algorithm was run for
30 generations, with 300 models each. The multi-object cost function
was computed as a weighted sum of 2 error functions accounting for the
criteria listed above (details in the Supplementary Material, Section
S1.3, Table S1).
The optimised Trovato2020 model was evaluated against Dataset
III, and on its ability to develop automaticity under specific conditions
(details in Section 2.3).
A population of models was generated using the optimised
Trovato2020 model as baseline, to reproduce the experimental varia-
bility observed in Dataset II, and to evaluate model stability to para-
meter variations (details in Section 2.4). Propagation of electrical ex-
citation in a 1D fibre using the optimised Trovato2020 model was also
simulated, to verify conduction velocity (CV) in control conditions, as
well as to test the potential propagation of spontaneous APs, EADs and
DADs in tissue, and to evaluate the effects of INa block on CV (details in
the Supplementary Material, Section 1.4).
2.3. Model validation
The optimised model was evaluated against the experimental
Dataset III, not considered during the model development and not used
for the calibration and optimisation of the initial model. The simula-
tions in control conditions and with dofetilide were conducted in si-
milar experimental conditions as for Dataset III, following the protocols
1 and 7 (Section 2.5), respectively.
Moreover, the potential for automaticity was investigated using the
protocol outlined below (Section 2.5), by modifying the balance be-
tween IK1 and If, which determined the DMP [2,7]. Furthermore, the
effect of hyperkalaemia was also investigated by increasing the extra-
cellular potassium concentration, since it has been shown to suppress
automaticity in human PCs [8].
2.4. Population of models
Using the optimised model as baseline, we constructed a population
of human Purkinje models, based on the methodology described in
[18,19]. This allowed to simulate the variability in AP morphology
observed in the experimental recordings (Table 1).
An initial population of 3000 models was constructed by sampling
all the main ionic current conductances, namely, INa, INaL, ICaL, ICaT, Ito,
Isus, IKr, IKs, If, IK1, INCX, INaK, in the range [50–200]% of their baseline
value, using Latin hypercube sampling [30]. The initial population was
then calibrated through a multi-step process, based on the criteria 1–3
used for the development of the Trovato2020 model and our human
experimental Datasets II and III.
In the first calibration step, only the models with all AP biomarkers
within the minimum and maximum experimental values at all BCLs
(Table 1) were selected. To constrain the AP plateau within the ex-
perimental traces, two additional biomarkers at 1 Hz were considered,
similar to [19]: the voltage level measured 25 and 50 ms after the AP
upstroke. In the second calibration step we selected only the models
showing APD90 rate-dependence in line with experiments. As third
calibration step, we selected only the models showing a direct depen-
dence of APD90 on ICaL.
Simulations in control conditions and with dofetilide were per-
formed for all models in the calibrated population, and results were
compared to the experimental Dataset III. Finally, EADs and DADs in-
ducibility was also tested using the calibrated population, to investigate
the mechanisms underlying EADs and DADs generation in human PCs.
To do this, protocols 5 and 6 (Section 2.5) were simulated for each
model in the calibrated population. EADs were identified when a po-
sitive derivative of the membrane potential was observed, from 150 ms
after the stimulus [31]. DADs were identified as a deflection of the
membrane potential larger than 1 mV during the diastolic phase. AP
biomarkers, current conductances and model dynamics were analysed
to identify the key mechanisms underlying EADs and DADs generation.
2.5. Stimulation protocols
Single cell model equations were implemented in Matlab
(Mathworks Inc. Natwick, MA, USA) and solved with the function
ode15s, an adaptive time step solver for stiff problems [32]. Data ana-
lysis was also performed using Matlab. Simulations for the population
of models were run on the Oxford supercomputer ARCUS (http://www.
arc.ox.ac.uk/). The monodomain formulation was used to simulate
propagation along the fibre [33] and was solved using the Fourier
spectral method for fractional diffusion [34]. The Rush-Larsen method
was implemented for the integration to speed up the simulations [35] in
Matlab.
The calibration and validation criteria described in Section 2.2 were
evaluated using 9 different simulation protocols, 6 for calibration, 2 for
validation and 1 for comparison against voltage-clamp experiments. A
list of the protocols is provided below:
1) Control conditions. Steady state (SS): 1000 beats at 1 Hz, to allow
the intracellular concentrations to reach stability.
2) Rate dependence. Starting from SS, 150 beats for each BCL, from
300 ms to 5000 ms.
3) ICaL modulation. Starting from SS, 150 beats at 1 Hz with up/down
regulation of the ICaL conductance (± 30%).
4) IKr block. Starting from SS, 150 beats at 1 Hz with IKr block (at 30%
and 50%).
5) EADs inducibility. Starting from SS, 150 beats at slow pacing
(BCL = 4000 ms) with 85% IKr block, as in [21].
6) DADs inducibility. Starting from SS, 1500 beats at fast pacing
(BCL = 300 ms, 3.3 Hz), with and without RyR hypersensitivity.
The model was then left unstimulated for 10s to allow for any po-
tential DADs or triggered APs to arise. RyR hypersensitivity was
simulated as an increased sensitivity to intracellular Ca2+ (+100%)
and a decrease in the release time constant (−70%), similar to [14].
7) Dofetilide. Starting from SS, 150 beats at 1 Hz and 2 Hz, using a
simple pore-block drug model [36] with IC50 (in μM) and Hill
coefficient (IC50/h) for IKr, INa and ICaL equal to 0.03/1.2, 162.1/1
and 26.7/1, respectively [37].
8) Automaticity. Starting from SS, 3 different combinations of If and IK1
were tested: i) 90% IK1 block; ii) increasing If 9-folds; iii) combining
the 2 conditions, 50% IK1 block and 4-folds If. The values of IK1 and If
conductances were identified through a sensitivity analysis up to
automaticity appearance. The model was stimulated for 150 beats at
1 Hz, followed by 15 s with no stimulation. The same simulations
were repeated under hyperkalaemia with extracellular [K+] set to
8 mM to reproduce the same conditions as in [8].
9) Voltage clamp simulations (for I-V curves). 1000 ms at holding
voltage (−40 for IK1 and− 50 mV for both Ito and Isus) followed by
a step (300 ms for Ito and 100 ms for both IK1 and Isus) at different
voltage values (from−120 mV to 0 mV for IK1, and from−50 mV to
C. Trovato, et al. Journal of Molecular and Cellular Cardiology 142 (2020) 24–38
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+60 mV for both Ito and Isus). Intracellular [Na+], [Ca2+] and [K+]
were set to 0.0001 mM, 0.0001 mM and 130 mM, respectively,
while their corresponding extracellular concentrations were
140 mM, 1 mM, 5.4 mM, respectively, as in the experiments by Han
et al. [9].
3. Results
3.1. Simulations with the optimised Trovato2020 model reproduce
experimental AP recordings and fulfil all calibration criteria
Optimisation using the genetic algorithm produced a Pareto optimal
front of 105 models, including many duplicates of 8 unique models. The
final optimised Trovato2020 model was identified as the model with
the best performance across all the tested protocols. Parameters and
simulation results for the 8 models are shown in Fig. S4. Table 2 reports
the simulated AP biomarkers for the optimised Trovato2020 vs the non-
optimised model, and the human experimental biomarker ranges from
Dataset II at 1 Hz.
Fig. 2 shows the simulation results for the optimised Trovato2020
model, reproducing Datasets I and II and satisfying each of the 6 cali-
bration criteria: simulations of voltage-clamp protocols for Ito, Isus and
IK1 to reproduce the experimental I–V curves from Dataset I (Panel A);
AP traces at 1 Hz and rate dependence in line with experimental re-
cordings from Dataset II (Panel B and C, respectively); APD90 changes
induced by ICaL modulation (Panel D) and IKr block (Panel E); EADs and
DADs inducibility (Panel F and G, respectively). Further information on
the ionic currents underlying the AP and Ca2+-transient in the opti-
mised model at 1 Hz are included in the Supplementary Material, Fig.
S5.
As expected, fast Na+ current activation drives the depolarisation
phase with dV/dtMAX = 381 mV/s, 24 mV voltage peak and 110 mV
amplitude (Table 2). During the early-repolarisation phase, simulated
AP (Fig. 2B) presents a “spike and dome” waveform (Fig. 2B inset), due
to the interplay between the depolarising currents ICaL and INaL and the
repolarising Ito and Isus. The repolarisation phase is driven by IKr, IKs and
IK1, resulting in APD90 of 306 ms at 1 Hz. The small diastolic depo-
larisation (~1 mV), due to the action of If, is in agreement with the
difference observed experimentally between potentials at take-off and
end of repolarization (EOP vs TOP). No automaticity was observed, in
agreement with experimental recordings from Dataset II and the lit-
erature [7]. The correlation coefficients between AP biomarkers and
ionic current conductance at 1 Hz are reported in Table S2.
Rate-dependence of APD90 is in line with experimental recordings
from Dataset II (Fig. 2C). At BCL = 400 ms, the APD90 is 250 ms and
increases up to 312 ms at BCL = 5000 ms. Furthermore, the optimised
model reproduces a positive correlation between APD and ICaL mod-
ulation (Fig. 2D): small changes in ICaL conductance affect the plateau
phase, with small changes in APD90 as reported for rabbit PCs [38].
However, a stronger ICaL block also causes APD90 shortening, as in ex-
perimental recordings using canine PCs [22,23].
Simulations with the new human Purkinje Trovato2020 model yield
APD prolongation following IKr block (Fig. 2E): 30% and 50% IKr blocks
prolong APD90 from 306 (control) to 365 and 421 ms, respectively,
whereas the same degrees of block in the human ventricular ORd model
prolong the APD90 from 269 ms (control) to 329 and 386 ms, respec-
tively. These results are in agreement with canine experiments [24]
showing a longer AP in Purkinje compared to ventricular myocytes,
both in control conditions and following IKr block.
EADs inducibility is shown in Fig. 2F: at BCL = 4000 ms, the AP
fully repolarises in control (APD90 = 307 ms, dashed line), whereas an
EAD occurs with 85% IKr block (solid line).
DADs inducibility is illustrated in Fig. 2G: following fast pacing, the
Trovato2020 model remains well polarised in control conditions (da-
shed line), while DADs occur when including RyR hypersensitivity
(solid line). The initial DADs amplitude is 6 mV, and it decreases to less
than 1 mV after 13 s. Even after 300 s, the model exhibits oscillations
albeit of amplitude smaller than 0.01 mV, and therefore potentially
undetectable experimentally. The ionic mechanisms of EADs and DADs
generation are investigated in Section 3.6 and 3.7.
Further analysis of the optimised Trovato2020 model is included in
the Supplementary Material, including the sensitivity analysis (Section
4, Fig. SA1–SA5).
3.2. Model validation: response to dofetilide and automaticity
Fig. 3A illustrates the agreement of simulation results with experi-
ments from Dataset III, in control conditions (blue) and with dofetilide
(red), at 1 and 2 Hz (left and right, respectively).
Fig. 3B illustrates the ability of the Trovato2020 model to display
automaticity following IK1 decrease and/or If increase. When including
either IK1 down-regulation, If up-regulation, or a combination of both,
the DMP increases much faster during the resting phase, and auto-
maticity is observed at BCL of 2.5, 1.6 and 1.9 s, respectively. These
results are in line with the BCL range of 1.3–3.0 s experimentally ob-
served by [8,15], and also with [2,39], reporting that PCs with less
negative DMP show automaticity, while well polarised PCs remain
quiescent. Hyperkalaemia stops the automaticity in the two scenarios
including If up-regulation, in agreement with experiments in human
PCs [8], whereas it increases the spontaneous firing rate when auto-
maticity is induced only by IK1 down-regulation.
3.3. Comparison with previous cardiac Purkinje in silico models
The Trovato2020 model was compared with two other human
Purkinje models available in the literature (TT08 and STW). Fig. S6A
depicts the simulated APs at 1 Hz for the three models with experi-
mental APs from Dataset II, while the corresponding AP biomarkers are
reported in Table S3. Simulation results obtained with both TT08 and
STW overestimate the rate of depolarisation (742 and 522 V/s, re-
spectively), compared to experiments from Datasets II and III, and the
literature, i.e., 388 ± 25 V/s [40] and 207 ± 26 V/s [8].
Trovato2020 and TT08 have similar DMP, whereas STW is sig-
nificantly less negative. Indeed, STW shows automaticity in control
conditions, while Trovato2020 reproduces the quiescent PCs in control,
and automaticity with less negative DMP. TT08 does not include any
formulation for the If, and it does not yield automaticity under the
protocols considered in this study (Section 2.5).
Both Trovato2020 and TT08 show an APD rate dependence in line
with the experiments (Fig. S6B), even if TT08 largely overestimates the
APD90 at all BCL, while STW shows a non-physiological rate depen-
dence. Simulations with TT08 and STW failed to reproduce EADs with
protocol 5 (Fig. S6C), only showing AP prolongation (17% and 42%,
respectively). Both TT08 and STW also underestimate the AP
Table 2
Simulated and experimental AP biomarkers.
Experiments Initial model Optimised model
dV/dtMax (V/s) 387 ± 143 435 381
APD90 (ms) 294 ± 76 249 306
APD75 (ms) 261 ± 67 225 279
APD50 (ms) 210 ± 52 168 223
APD25 (ms) 117 ± 46 116 142
APD10 (ms) 33 ± 35 49 34
APA (mV) 106 ± 7 113 110
TOP (mV) −85 ± 2.4 −86.7 −86.5
EOP (mV) −86 ± 2 −87.2 −87.3
Comparison between experimental and simulated AP biomarkers using the in-
itial and optimised models at 1 Hz (mean ± std).
dV/dtMAX: maximum upstroke velocity; APDx: AP duration at X% of repolar-
isation; APA: action potential amplitude; TOP: membrane potential before
depolarisation; EOP: membrane potential at the end of repolarisation.
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prolongation induced by dofetilide (Fig. S6D), compared to our Dataset
III. Finally, neither TT08 nor STW are capable of developing DADs at
fast pacing, even when considering RyR hypersensitivity. Therefore, the
novel Trovato2020 model is more suitable than both TT08 and STW for
mechanistic investigations of arrhythmias considering EADs, DADs,
triggered activity as well as APD rate dependence.
The Trovato2020 model was also compared with the ORd and PRd
models: simulated AP biomarkers are reported in Table S3, whereas,
APs, intracellular Ca2+ concentrations and the three refitted K+ cur-
rents, Ito, Isus, IK1, at 1 Hz are reported in Fig. S6E. The simulated AP
with the Trovato2020 model displays a smaller peak potential than
both ORd and PRd, faster upstroke velocity than ORd but slower than
PRd, AP plateau similar to PRd and lower than ORd, and finally, APD90
longer than ORd but shorter than PRd. Intracellular [Ca2+] is smaller
with the Trovato2020 model than with ORd, but similar to the one with
PRd, which was based on experimental data from canine PCs [41]. In
particular, Trovato2020 and PRd have the same level of diastolic
[Ca2+] and same delay in the Ca elevation time (~100 ms). Similarly,
the [Ca2+] of the sub membrane compartment obtained with the Tro-
vato2020 was similar to the one simulated with PRd, whereas the ORd
does not implement such compartment.
The refitted K+ currents Ito, Isus and IK1 were compared as well (Fig.
S6E). The simulated Ito with Trovato2020 is bigger than with ORd but
smaller than PRd, as suggested by experiments in human and canine
PCs [9,42]. In all three models, its contribution ends after 20 ms. Isus,
not implemented in ORd, displays lower amplitude in Trovato2020
than in PRd, similarly to Ito. Simulated IK1 with Trovato2020 is smaller
than both ORd and PRd, in line with the reduced level of expression of
IK1 proteins in human Purkinje [43,44].
Trovato2020, ORd and PRd share the same model for CaMKII sig-
nalling [45]. Similarly to the ORd, removing CaMKII from the Tro-
vato2020 model (Fig. S7A) reduces intracellular and submembrane
[Ca2+] peak, with minimum changes on the APD and [Ca2+] rate-de-
pendence. The decreased [Ca2+] due to CaMKII signalling removal had
no effects on DADs induced at fast pacing with RyR hypersensitivity
(Fig. S7B), though also the sarcoplasmic [Ca2+] was reduced. No effects
were observed on EADs dynamics, as expected due to the low pacing
frequency.
3.4. A population of human Purkinje Trovato2020 models accounting for
biological variability
The optimised human Trovato2020 model was used as baseline to
construct a population of models, to capture the biological variability in
the AP morphology observed in the experimental Dataset II. The initial
population (n = 3000) was calibrated through a multi-step filtering
process, as described in Methods, and summarised in Fig. 4.
In the first calibration step, only the models in agreement with the
experimental biomarkers at all BCLs were selected (n = 1025), while
the others were discarded (n = 1975). Fig. 4A reports the simulated
APs for the baseline Trovato2020 model, the initial population and the
experimental traces at 1 Hz. In the second calibration step, n = 867
models showed APD90 rate dependence in line with the experiments
and were kept in the population (Fig. 4B). In the last calibration step,
n = 497 models were accepted into the final population, all displaying
a positive correlation between APD and ICaL (Fig. 4C). These models
were used for all subsequent investigations.
Fig. 4D illustrates the APD distribution in the population, both in
control conditions (blue) and with dofetilide (pink), at 1 Hz and 2 Hz
(left and right, respectively), compared against the experimental APD
values from Dataset III. Simulation results for the population are in
agreement with the experimental values in control conditions and with
dofetilide at 1 Hz. The simulated APs with the population yield a wider
range of APD prolongation compared to experiments, similar to what
was previously shown for rabbit PCs [19].
3.5. EADs mechanisms
When simulating the EADs protocol (described in Section 2.5) in the
experimentally-calibrated population of models (Fig. 4E, top panel),
59% of the models (n = 296) developed EADs (pink traces), while the
rest of the models only displayed AP prolongation (blue traces). Mul-
tiple EAD phenotypes were observed, in agreement with previous ex-
perimental and simulation studies [31,46,47]. The distribution of the
ionic current conductances (Fig. 4E, bottom panel) highlights the dif-
ferences between these two groups of models. Models displaying EADs
were mainly characterised by larger inward current conductances (GCaL
and GNaL), in agreement with the sensitivity analysis results (Supple-
mental Material, Section 4, Figure SA4). ICaL re-activation (Fig. 5A) was
identified as the key mechanism for EAD generation [48,49] whereas,
no INaL reactivation was observed with the protocol used in this study
[50]. Fig. 5B reports intracellular and sub membrane [Ca2+] peak va-
lues in control using the models displaying only AP prolongation and
those developing EADs.
3.6. DADs mechanisms
When simulating the DADs protocol (described in Section 2.5) in the
experimentally-calibrated population (Fig. 4F, top panel), 63 models
developed DADs (pink traces), 5 models developed triggered APs (green
traces), while no DADs were observed in the remaining models (blue
traces). The distribution of the ionic current conductances (Fig. 4F,
bottom panel) highlighted the differences between these three groups
of Purkinje models. Human virtual PCs displaying DADs had larger
GCaL, and reduced GNCX.
Fig. 5C illustrates the ionic mechanisms underlying DADs forma-
tion. Models displaying DADs showed higher Ca2+ concentrations in all
intracellular compartments, including the SR. In particular, in all
models displaying DADs, [Ca2+]NSR was larger than 1.7 mM, in line
with previous computational studies [51–53] and also larger than in the
baseline model with RyR hypersensitivity (1.1 mM, Fig. S7B). Ca2+
accumulation made the cell more vulnerable to spontaneous SR Ca2+
release, which were translated by the INCX into the depolarising currents
causing DADs. Fig. 5D shows intracellular and submembrane [Ca2+]
amplitudes, i.e., the difference between the diastolic concentration and
the peak value for each cellular compartment, and the average sarco-
plasmic [Ca2+] of the models staying quiescent and those developing
DADs and triggered APs across the whole calibrated population.
In order to establish the link between the distribution of ionic cur-
rent conductances and Ca2+ accumulation in the models displaying
DADs, we performed additional ad hoc simulations for a selection of 3
models from the population. We selectively restored ionic current
conductances to their baseline values, and evaluated changes in Ca2+
accumulation and DADs generation. Large GCaL and small GNCX directly
contributed to Ca2+ overload and DADs generation: restoring the value
of either of these conductances to their baseline significantly reduced
intracellular Ca2+ concentrations, and also abolished DADs (Fig. S8,
Panel A and B).
Fig. 2. Simulations results obtained with the optimised Trovato2020 model (black), compared against the corresponding experimental data (green), when available:
A) I-V curves for IK1 (left), Ito (middle) and Isus (right). Experimental data from Dataset I [9]. B) AP traces at 1 Hz. Experimental data from Dataset II. C) APD90 rate-
dependence. Experimental data from Dataset II. D) AP changes induced by ICaL conductance modulation. E) AP changes induced by IKr block. F) EADs observed at
slow pacing with IKr block. G) DADs following fast pacing with RyR hypersensitivity. No DADs were observed in control. (For interpretation of the references to
colour in this figure legend, the reader is referred to the web version of this article.)
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Triggered APs were observed in ~1% of the experimentally-cali-
brated population (n= 5 models). All models developing triggered APs
were characterised by smaller GK1 and GNaK (Fig. 4F), both reducing the
outward current during the diastolic phase, and had higher intracellular
Ca2+ concentrations, compared to the ones developing DADs only
(Figure 5B).
3.7. Simulation results in a human Purkinje 1D fibre
Fig. 6 summarises the simulations results for the human Purkinje 1D
fibre considering the optimised Trovato2020 model in control condi-
tions (Fig. 6A) and one of the model variants displaying automaticity in
single cell as reported in Section 3.2 (Fig. 6B). Spontaneous APs pro-
pagated along the whole fibre, with no changes in the BCL compared to
single cell simulations. Fig. 6C shows the results with the optimised
Trovato2020 model and the EADs protocol: EADs were observed in the
whole fibre, with no changes in EADs amplitude induced by the inter-
cellular coupling. Fig. 6D shows the results of one of the models in the
population developing both triggered APs and DADs at fast pacing
(Fig. 5C): in this case, the electrical coupling affected the simulations
since only a single triggered APs was observed in fibre, compared to the
2 observed in the single cell simulations. After the fast pacing, the fibre
depolarised generating one DAD (t = 550 ms, Fig. 6D) but it did not
reach the threshold to allow fast Na+ channels opening. Though, after
another further 650 ms the membrane reached the threshold and a
spontaneous AP was elicited, followed by 2 DADs, as in the single cell
simulations. However, when the electrophysiological changes under-
lying EADs and DADs were applied only to the central portion of the
fibre (1.67 cm, 33 nodes), abnormalities did not propagate due to the
sink-source mismatch as previously reported by Xie et al. [54].
INa block caused reduction in CV (Table S4): for INa blocks of 30%,
50% and 90%, CV decreased by 8%, 15% and 45%, respectively,
compared to the control value of 160 cm/s. Even with 95% INa block,
the AP was still able to propagate, even though CV was reduced to
69 cm/s (−57%). AP failed to propagate only with a complete block of
INa.
4. Discussion
4.1. The novel human Purkinje AP model
In this study, the novel human PC Trovato2020 model was pre-
sented, including its construction, calibration, optimisation and in-
dependent evaluation using experimental AP recordings from un-
diseased human PCs and knowledge about Purkinje-specific currents
and Ca2+-handling. Parameter optimisation was performed using a
multi-objective genetic algorithm and sensitivity analysis, to overcome
manual tuning limitations. Independent model validation was con-
ducted using AP recordings from undiseased human PCs in control and
with dofetilide, and also based on the model's ability to reproduce
EADs, DADs and trigger activity using specific protocols. Both single
cell and 1D fibre simulations were performed using a variety of sti-
mulation protocols. In addition, an experimentally-calibrated popula-
tion of human PC models was also constructed to account for biological
variability, and used to investigate the ionic mechanisms underlying
EADs and DADs generation in human PCs. The main findings of this
study are:
1. Simulation results with the Trovato2020 model are in agreement
with the key features of human Purkinje APs reported in the human
experimental datasets presented in this study and from the litera-
ture. Simulations reproduce a wide range of stimulation protocols,
including different pacing frequencies and selective channel blocks.
2. The Trovato2020 model is able to yield and explain pro-arrhythmic
mechanisms, i.e. EADs and DADs, in human PCs. Simulations show
that 59% of the PCs models in the population display EADs caused
by ICaL reactivation and favoured by strong ICaL and INaL. DADs are
observed in 13% of the Purkinje population models, displaying Ca2+
accumulation both in the intracellular space and into the sarco-
plasmic reticulum. Triggered APs were observed in 1% of the virtual
PCs, which displayed strong downregulation of IK1 and INaK.
3. Integration of the Trovato2020 model in a 1D fibre succeed to re-
produce AP propagation, automaticity, EADs, DADs and triggered
APs in tissue. It can be implemented in higher scale models for in-
vestigation also at tissue and organ level.
The Trovato2020 Purkinje model integrates and expands a large
amount of knowledge and experimental data obtained from human
Purkinje preparations. It is the first human Purkinje model in-
corporating a Ca2+ handling with the 3 SR compartments and 3 dif-
ferent types of Ca2+ releases, based on the Purkinje-specific structure
[55] already implemented for rabbit [19] and canine [14] models.
Previously published human Purkinje models [15–17] include only 2
intracellular compartments and 1 type of Ca2+ release, inherited from
ventricular models. Thus, they do not account for Purkinje specific
features such as the low density of t-tubuli and different type of Ca2+
releases. A physiological Purkinje Ca2+-handling representation is
crucial, since it can favour arrhythmogenesis in pathology [1] and upon
pharmacology interventions [13]. The Purkinje-specific Ca2+ handling
model introduces a delay in the Ca2+ diffusion from the sub-membrane
to the cellular bulk, and therefore, an intracellular [Ca2+] gradient (Fig.
S5). The simulated [Ca2+]i of the new Purkinje model in control con-
ditions is smaller and delayed compared to the [Ca2+] in the sub-
membrane space as reported by [55–57]. The smaller Ca2+ transient is
correlated with scarce myofibrils, according to the lower contractile
ability of Purkinje compared to ventricular cardiomyocytes [13].
Simulations with the human Purkinje Trovato2020 model revealed
that the balance between IK1 and If determines the DMP and, therefore
also automaticity, as previously suggested experimentally by [2,58].
The simulation results are also in agreement with [8], in showing pa-
cemaker activity in human PCs with elevated diastolic transmembrane
potential (TOP ~ −70) in control condition. Hyperkalaemia stopped
pacemaker activity, as also reported experimentally [8], but only when
automaticity was due to If up-regulation, since high potassium con-
centration up-regulates IK1 making the resting more stable. This does
not occur when automaticity was induced only by IK1 down-regulation,
suggesting a more physiological role of If in setting PC automaticity
compared to pure IK1 down-regulation’. Heterogeneity in the DMP and
automaticity may lead to conduction block, creating the substrate for
micro and/or macro re-entry, and eventually arrhythmia [1].
The human Purkinje Trovato2020 model was also able to reproduce
the effects of potassium and calcium channel block on repolarization
properties, as well as sodium channel block on electrical propagation.
The simulation results were in agreement with human experimental
data acquired at several frequencies, both in control conditions and
following dofetilide application. Simulations with dofetilide at 2 Hz
(Fig. 4D) showed reverse rate-dependence, i.e., less prolongation at
higher frequencies, in agreement with observations both in human and
Fig. 3. Independent validation of the optimised Trovato2020. A) Comparison between the human experimental AP traces from Dataset III (top panels, n= 3) and the
simulations with the Trovato2020 model (bottom panels), in control conditions (blue) and with Dofetilide 100 nM (red), at 1 Hz (left) and 2 Hz (right). B) Ability of
the model to develop automaticity when no external stimulus (blue asterisks) is applied. Simulations are shown both with normal [K+]o (black) and under hy-
perkalaemia conditions (light blue), in four different scenarios. (For interpretation of the references to colour in this figure legend, the reader is referred to the web
version of this article.)
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animal preparations [59], while a larger APD prolongation is observed
in the human recordings from Dataset III. These results lend credibility
to the new model for in silico drug trials in human PCs to assess drug
efficacy and/or drug-induced cardiotoxicity, as done using human
ventricular models [60].
4.2. EADs and DADs mechanisms
Afterdepolarisations in Purkinje cardiomyocytes can act as triggers
of ectopic activity and arrhythmia, particularly in diseased or drug
action conditions [1]. The Trovato2020 model is the first human Pur-
kinje model able to reproduce EADs, DADs and triggered AP in single
cell and 1D fibre. This enables the investigation of PCs as arrhythmia
triggers [61,62], in addition to their contribution to the substrate for re-
entry circuits and retrograde propagation [63,64]. Therefore, the in-
tegration of the Trovato2020 model in tissue or whole-ventricular
models, including the Purkinje tree [65,66], could enable investigations
into the role of PCs in human ventricular arrhythmias, caused by re-
levant disease conditions such as myocardial infarction [67–71], is-
chemic heart disease [72,73], structural heart disease [74], CPVT [75],
post-shock arrhythmia [64], Brugada and Long QT syndromes, both
acquired or drug-induced [3,76,77].
In this study, pro-arrhythmic electrical abnormalities i.e. EADs,
DADs and triggered APs were investigated at cellular and fibre scale
also including biological variability through the population of models
approach. Our simulations report that EADs, DADs and triggered APs
are based on different ionic mechanisms, which are consistent with
previous investigations in other species [2,14,78,79].
Across all the simulations, EADs were uniquely due to ICaL re-
activation, and occurred in models with strong ICaL upregulation, and
also with high INaL. This is consistent with simulation results using
human ventricular models [31,60]. No INaL re-activation was observed
during EADs, although this may occur using a different protocol [50].
Simulations in tissue confirmed that EADs are able to propagate along
the whole fibre and demonstrated the possibility of using the model to
investigate PCs as arrhythmia trigger in tissue and whole-organ simu-
lations.
Moreover, across the population of models, DADs generation re-
quired Ca2+ accumulation both in the SR and in the intracellular space
at fast pacing (Fig. 5B). DADs and triggered APs in PCs have been
clinically related to arrhythmia initiation [1]. They are suspected to
trigger postshock arrhythmias such as ventricular tachycardia and fi-
brillation after a successful defibrillation of the heart [52]. The me-
chanisms underlying DADs have been difficult to unravel, but many
experimental and simulation studies identified the important role of
Ca2+ dynamics [1]. In general, experiments across a wide range of
protocols, suggested that the key feature for DADs generation is Ca2+
overload, though the mechanisms necessary for DADs are still being
debated [53]. Our study suggests a similar mechanism also in human
Purkinje cells, and identifies ICaL and INCX as the ionic currents playing a
major role in DADs inducibility, and IK1 and INaK for triggered APs. The
present study helps in the translation from animal to human studies,
and provides a new and needed tool for in silico investigation of ar-
rhythmia, including the Purkinje system and its electrophysiology.
4.3. Limitations
The Trovato2020 model presented in this study was built using the
human ventricular ORd model, the Purkinje-specific Ca2+ sub-system,
cellular compartments and intracellular ionic fluxes of the canine PRd
model and experimental human data. The model was calibrated using
the only currently available dataset from undiseased human PC and
validated against an independent experimental dataset from human
undiseased hearts in control and with dofetilide, not used for the model
calibration and optimisation. The latter also represent the first pub-
lished dataset from undiseased human PCs under drug action. We
cannot exclude the possibility that connexin-mediated electrotonic in-
teractions between PCs and ventricular tissue might have affected the
AP waveforms of our experimental datasets, in particular, during the
early repolarisation phase. A limitation of this study is the lack of ex-
perimental data on the Ca2+ transients in human cardiac PCs, since
there are no recordings available. Data on human PCs AP response to
pure ICaL modulations are also lacking. However, previous studies using
animal Purkinje and human ventricular preparations suggest positive
correlation between APD90 and ICaL modulation. Preparations used in
Dataset I were obtained from failing hearts, which could affect Ito, Isus,
IK1 measurements. This uncertainty was tackled in our study through a
population of models investigation using hundreds of models. During
the model development, we used the original ORd human ventricular
current formulation of currents, whose data were no available for
human PCs (e.g., IKs, INCX, INaK). This is further supported by the fact
that there are no reports on different isoforms in human ventricular
versus Purkinje cardiomyocytes. If and ICaT formulations were adopted
from the canine PRd model. However, ICaT does not play an important
role in PCs dynamics and abnormalities, and there are no reports of
significant differences between canine and human If in PCs.
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